Latest News and Press Releases

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "DYSPORT Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report provides detailed insights...

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Prog

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

Transition brings enhanced patient experience and Botox, lip filler, and other med spa treatments.

AEON Biopharma Appoints John Bencich as Chief Financial Officer

AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong